Lv4
560 积分 2022-11-04 加入
Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients
2天前
已完结
Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients With Gallbladder Cancer
1个月前
已完结
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
10个月前
已完结
Immunogenic Cell Death in Cancer Therapy
10个月前
已完结
Immunology and immunotherapy of cholangiocarcinoma
10个月前
已完结
Molecular targeted therapies: Ready for “prime time” in biliary tract cancer
1年前
已完结
Evolving therapeutic landscape of advanced hepatocellular carcinoma
1年前
已完结
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
1年前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
1年前
已完结
皖公网安备34019202002308
